Regulation of mitochondrial permeability transition pore by PINK1

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Gautier, Clement A ^a,d   Giaime, Emilie ^a   Caballero, Erica ^b   Nú̃ez, Lucía ^b   Song, Zhiyin ^c   Chan, David ^c   Villalobos, Carlos ^b   Shen, Jie ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Calcium; Mitochondrial permeability transition pore; Mitochondrial respiration; Mitochondrial transmembrane potential; Parkinsons disease

Indexed keywords

MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHOTRANSFERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PTEN INDUCED KINASE 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; ENZYME ACTIVITY; FIBROBLAST; LOSS OF FUNCTION MUTATION; MEMBRANE STRUCTURE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; REGULATORY MECHANISM; ANIMAL; BRAIN; CELL CULTURE; CELL RESPIRATION; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE MUTANT; PARKINSON DISEASE; PHYSIOLOGY;

ANIMALS; BRAIN; CELL RESPIRATION; CELLS, CULTURED; FIBROBLASTS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEURONS; PARKINSON DISEASE; PROTEIN KINASES;

EID: 84861381591     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-22     Document Type: Article

References (59)

1. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW, Science 2004 304 1158 1160 10.1126/science.1096284 15087508 (Pubitemid 38661852)
2. The kinase domain of mitochondrial PINK1 faces the cytoplasm. Zhou C, Huang Y, Shao Y, May J, Prou D, Perier C, Dauer W, Schon EA, Przedborski S, Proc Natl Acad Sci U S A 2008 105 12022 12027 10.1073/pnas.0802814105 18687899
3. Mitochondrial complex I deficiency in Parkinson's disease. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD, Lancet 1989 1 1269 2566813 (Pubitemid 19140359)
4. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Langston JW, Ballard P, Tetrud JW, Irwin I, Science 1983 219 979 980 10.1126/science.6823561 6823561 (Pubitemid 13189531)
5. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT, Nat Neurosci 2000 3 1301 1306 10.1038/81834 11100151
6. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J, Nature 2006 441 1157 1161 10.1038/nature04788 16672980 (Pubitemid 43990737)
7. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M, Nature 2006 441 1162 1166 10.1038/nature04779 16672981 (Pubitemid 43990738)
8. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. Poole AC, Thomas RE, Yu S, Vincow ES, Pallanck L, PLoS One 2010 5 10054 10.1371/journal.pone.0010054 20383334
9. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Deng H, Dodson MW, Huang H, Guo M, Proc Natl Acad Sci U S A 2008 105 14503 14508 10.1073/pnas.0803998105 18799731
10. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Kruger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C, J Neurosci 2007 27 12413 12418 10.1523/JNEUROSCI.0719-07.2007 17989306 (Pubitemid 350085485)
11. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, Haddad D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, Van Coster R, Wurst W, Scorrano L, De Strooper B, EMBO Mol Med 2009 1 99 111 10.1002/emmm.200900006 20049710
12. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. Dagda RK, Cherra SJ, Kulich SM, Tandon A, Park D, Chu CT, J Biol Chem 2009 284 13843 13855 10.1074/jbc.M808515200 19279012
13. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lammermann K, Brunner B, Kurz-Drexler A, Vogel F, Reichert AS, Bouman L, Vogt-Weisenhorn D, Wurst W, Tatzelt J, Haass C, Winklhofer KF, J Biol Chem 2009 284 22938 22951 10.1074/jbc.M109.035774 19546216
14. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Yu W, Sun Y, Guo S, Lu B, Hum Mol Genet 2011 20 3227 3240 10.1093/hmg/ddr235 21613270
15. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, Downward J, Latchman DS, Tabrizi SJ, Wood NW, Duchen MR, Abramov AY, Mol Cell 2009 33 627 638 10.1016/j.molcel.2009.02.013 19285945
16. Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects. Amo T, Sato S, Saiki S, Wolf AM, Toyomizu M, Gautier CA, Shen J, Ohta S, Hattori N, Neurobiol Dis 2010 41 111 118 20817094
17. Mitochondrial respiratory dysfunction in familiar parkinsonism associated with PINK1 mutation. Piccoli C, Sardanelli A, Scrima R, Ripoli M, Quarato G, D'Aprile A, Bellomo F, Scacco S, De Michele G, Filla A, Iuso A, Boffoli D, Capitanio N, Papa S, Neurochem Res 2008 33 2565 2574 10.1007/s11064-008-9729-2 18473170
18. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Gautier CA, Kitada T, Shen J, Proc Natl Acad Sci U S A 2008 105 11364 11369 10.1073/pnas.0802076105 18687901
19. Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. Gegg ME, Cooper JM, Schapira AH, Taanman JW, PLoS One 2009 4 4756 10.1371/journal.pone.0004756 19270741
20. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Muller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, Garcia-Arencibia M, Fernandez-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, Rub U, Chen A, Nussbaum RL, Auburger G, PLoS ONE 2009 4 5777 10.1371/journal.pone.0005777 19492057
21. Bioenergetic consequences of PINK1 mutations in Parkinson disease. Abramov AY, Gegg M, Grunewald A, Wood NW, Klein C, Schapira AH, PLoS One 2011 6 25622 10.1371/journal.pone.0025622 22043288
22. Indirect regulation of presenilins in CREB-mediated transcription. Watanabe H, Smith MJ, Heilig E, Beglopoulos V, Kelleher RJ, Shen J, J Biol Chem 2009 284 13705 13713 10.1074/jbc.M809168200 19289467
23. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Frezza C, Cipolat S, Scorrano L, Nat Protoc 2007 2 287 295 10.1038/nprot.2006.478 17406588 (Pubitemid 47040043)
24. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F, Biophys J 1999 76 725 734 10.1016/S0006- 3495(99)77239-5 9929477 (Pubitemid 29264555)
25. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC, J Cell Biol 2003 160 189 200 10.1083/jcb.200211046 12527753 (Pubitemid 36254953)
26. Visualization and quantification of mitochondrial dynamics in living animal cells. De Vos KJ, Sheetz MP, Methods Cell Biol 2007 80 627 682 17445716
27. Presenilins are essential for regulating neurotransmitter release. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, Sudhof TC, Shen J, Nature 2009 460 632 636 10.1038/nature08177 19641596
28. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease. Peng M, Falk MJ, Haase VH, King R, Polyak E, Selak M, Yudkoff M, Hancock WW, Meade R, Saiki R, Lunceford AL, Clarke CF, Gasser DL, PLoS Genet 2008 4 1000061 10.1371/journal.pgen.1000061 18437205 (Pubitemid 351656696)
29. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Ichas F, Mazat JP, Biochim Biophys Acta 1998 1366 33 50 10.1016/S0005-2728(98)00119-4 9714722 (Pubitemid 28467021)
30. Imaging the mitochondrial permeability transition pore in intact cells. Petronilli V, Miotto G, Canton M, Colonna R, Bernardi P, Di Lisa F, Biofactors 1998 8 263 272 10.1002/biof.5520080314 9914828 (Pubitemid 29021357)
31. Mitochondria and cell death. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F, Mechanistic aspects and methodological issues. Eur J Biochem 1999 264 687 701
32. Imaging the permeability pore transition in single mitochondria. Huser J, Rechenmacher CE, Blatter LA, Biophys J 1998 74 2129 2137 10.1016/S0006-3495(98) 77920-2 9545072 (Pubitemid 28157948)
33. Mitochondrial permeability transition can be directly monitored in living neurons. Gillessen T, Grasshoff C, Szinicz L, Biomed Pharmacother 2002 56 186 193 10.1016/S0753-3322(02)00184-1 12109811 (Pubitemid 34628381)
34. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Halestrap AP, Davidson AM, Biochem J 1990 268 153 160 2160810 (Pubitemid 20166664)
35. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL, Cell 1991 66 807 815 10.1016/0092-8674(91)90124-H 1715244 (Pubitemid 121001714)
36. Bongkrekic acid. An inhibitor of the adenine nucleotide translocase of mitochondria. Henderson PJ, Lardy HA, J Biol Chem 1970 245 1319 1326 4245638
37. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T, J Neurosci 1998 18 5151 5159 9651198 (Pubitemid 28311932)
38. Role of alpha-tocopherol in the regulation of mitochondrial permeability transition. Yorimitsu M, Muranaka S, Sato EF, Fujita H, Abe K, Yasuda T, Inoue M, Utsumi K, Physiol Chem Phys Med NMR 2004 36 95 107 16268121 (Pubitemid 41571595)
39. Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. Reid AB, Kurten RC, McCullough SS, Brock RW, Hinson JA, J Pharmacol Exp Ther 2005 312 509 516 15466245 (Pubitemid 40189547)
40. The PINK1/Parkin pathway regulates mitochondrial morphology. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ, Proc Natl Acad Sci U S A 2008 105 1638 1643 10.1073/pnas.0709336105 18230723 (Pubitemid 351346567)
41. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B, Proc Natl Acad Sci U S A 2008 105 7070 7075 10.1073/pnas.0711845105 18443288 (Pubitemid 351754531)
42. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, Ahmad R, Miller DW, Zambrano I, Cowburn RF, Behbahani H, Cedazo-Minguez A, Cookson MR, PLoS ONE 2009 4 5701 10.1371/journal.pone.0005701 19492085
43. Local control of mitochondrial membrane potential, permeability transition pore and reactive oxygen species by calcium and calmodulin in rat ventricular myocytes. Odagiri K, Katoh H, Kawashima H, Tanaka T, Ohtani H, Saotome M, Urushida T, Satoh H, Hayashi H, J Mol Cell Cardiol 2009 46 989 997 10.1016/j.yjmcc.2008.12.022 19318235
44. The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells. Shim JH, Yoon SH, Kim KH, Han JY, Ha JY, Hyun DH, Paek SH, Kang UJ, Zhuang X, Son JH, Mitochondrion 2011 11 707 715 10.1016/j.mito.2011.05.013 21664494
45. Regulation of the permeability transition pore in skeletal muscle mitochondria. Fontaine E, Eriksson O, Ichas F, Bernardi P, Modulation By electron flow through the respiratory chain complex i. J Biol Chem 1998 273 12662 12668
46. Effect of transient and permanent permeability transition pore opening on NAD(P)H localization in intact cells. Dumas JF, Argaud L, Cottet-Rousselle C, Vial G, Gonzalez C, Detaille D, Leverve X, Fontaine E, J Biol Chem 2009 284 15117 15125 10.1074/jbc.M900926200 19346250
47. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C, J Neurosci Res 2002 69 257 267 10.1002/jnr.10282 12111807 (Pubitemid 34734156)
48. Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure. Sharov VG, Todor A, Khanal S, Imai M, Sabbah HN, J Mol Cell Cardiol 2007 42 150 158 10.1016/j.yjmcc.2006.09.013 17070837 (Pubitemid 44958623)
49. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease. Liu W, Vives-Bauza C, Acin-Perez R, Yamamoto A, Tan Y, Li Y, Magrane J, Stavarache MA, Shaffer S, Chang S, Kaplitt MG, Huang XY, Beal MF, Manfredi G, Li C, PLoS One 2009 4 4597 10.1371/journal.pone.0004597 19242547
50. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. Heeman B, Van den Haute C, Aelvoet SA, Valsecchi F, Rodenburg RJ, Reumers V, Debyser Z, Callewaert G, Koopman WJ, Willems PH, Baekelandt V, J Cell Sci 2011 124 1115 1125 10.1242/jcs.078303 21385841
51. Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cells. Maj MC, Tkachyova I, Patel P, Addis JB, Mackay N, Levandovskiy V, Lee J, Lang AE, Cameron JM, Robinson BH, Biochem Biophys Res Commun 2010 399 331 335 10.1016/j.bbrc.2010.07.033 20637729
52. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Ichas F, Jouaville LS, Mazat JP, Cell 1997 89 1145 1153 10.1016/S0092-8674(00)80301-3 9215636 (Pubitemid 127678747)
53. Calcium elevation in mitochondria is the main Ca2+ requirement for mitochondrial permeability transition pore (mPTP) opening. Baumgartner HK, Gerasimenko JV, Thorne C, Ferdek P, Pozzan T, Tepikin AV, Petersen OH, Sutton R, Watson AJ, Gerasimenko OV, J Biol Chem 2009 284 20796 20803 10.1074/jbc.M109.025353 19515844
54. Distinct characteristics of Ca(2+)-induced depolarization of isolated brain and liver mitochondria. Vergun O, Reynolds IJ, Biochim Biophys Acta 2005 1709 127 137 10.1016/j.bbabio.2005.07.006 16112074 (Pubitemid 41207740)
55. Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. Cox DA, Conforti L, Sperelakis N, Matlib MA, J Cardiovasc Pharmacol 1993 21 595 599 10.1097/00005344-199304000-00013 7681905 (Pubitemid 23095350)
56. Study on the relationship between calcium-induced calcium release from mitochondria and PTP opening. Huang X, Zhai D, Huang Y, Mol Cell Biochem 2000 213 29 35 10.1023/A:1007138818124 11129955
57. Mitochondrial pathology in Parkinson's disease. Schapira AH, Mt Sinai J Med 2011 78 872 881 10.1002/msj.20303 22069211
58. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J, J Biol Chem 2004 279 18614 18622 10.1074/jbc.M401135200 14985362 (Pubitemid 38623283)
59. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A, J Biol Chem 2005 280 34025 34032 10.1074/jbc.M505143200 16079129 (Pubitemid 41443124)